(PharmaNewsWire.Com, February 07, 2020 ) Substantial growth was observed in the global electrophoresis reagents market in the last decade, majorly due to an expected increase in the global burden of infectious diseases, genetic disorders, & cancer; significant investments by governments in genomics and proteomics; technological advancements; and rapid increase in geriatric population in developed countries.
The electrophoresis reagents market is segmented based on products, end users, techniques, applications, and regions. Based on products, the market is segmented into gels, dyes, buffers, and other electrophoresis reagents. Electrophoresis gels are subsegmented into polyacrylamide gels, agarose gels, and starch gels; dyes are subsegmented into ethidium bromide (EtBr), SYBR, and other dyes; and buffers are subsegmented into tris borate EDTA (TBE) buffers, tris acetate EDTA (TAE) buffers, and other buffers.
Based on technique, the electrophoresis reagents market is segmented into gel electrophoresis and capillary electrophoresis. Based on end users, the market is segmented into academic & research institutions, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users. On the basis of applications, the market is segmented into protein analysis and DNA & RNA analysis.
In 2014, the electrophoresis gels segment accounted for the largest share of the electrophoresis reagents market. However, the electrophoresis dyes segment is expected to be the fastest-growing segment in this market during the forecast period of 2015-2020. The high growth in this segment can be attributed to increasing investments and efforts by market players to find safer and highly sensitive alternative dyes for electrophoresis analysis.
The electrophoresis reagents market in the Asia-Pacific region is expected to offer significant growth opportunities for market players during the forecast period. The high growth in this regional segment is majorly attributed to the rapidly improving healthcare infrastructure, rising per capita income, increasing funding for genomics and proteomics research, rising demand for cutting-edge technologies, and low labor costs in emerging APAC countries.
The prominent players in the electrophoresis reagents market include Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Lonza Group (Switzerland), QIAGEN N.V. (Netherlands), and Merck Millipore (U.S.), among others.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
